Evidence mapPaperPMID 41884102Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026

Evolving PCOS Management: From Symptom Control to Phenotype-Targeted Therapy.

Tong Wang, Tianhong Zhang, Jingyuan Wang, Tao Lu

Abstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tong WangDepartment of Reproduction, Qingdao Municipal Hospital, Qingdao, 266071, People's Republic of China.
Tianhong ZhangDepartment of Gynecology, Qingdao Municipal Hospital, Qingdao, 266071, People's Republic of China.
Jingyuan WangDepartment of Reproduction, Qingdao Municipal Hospital, Qingdao, 266071, People's Republic of China.
Tao LuDepartment of Gynecology, Qingdao Municipal Hospital, Qingdao, 266071, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) constitutes a prevalent endocrine and metabolic disorder that substantially compromises reproductive and metabolic health in women of reproductive age. The escalating global prevalence of this multisystem condition underscores the need for innovative, interdisciplinary management strategies. Unlike existing reviews, this paper offers a distinctive synthesis of recent advances in PCOS clinical management, with a novel focus on integrating lifestyle modifications, pharmacological interventions, assisted reproductive techniques, and emerging therapeutic approaches such as digital health tools and personalized medicine. It critically evaluates the mechanisms, efficacy, and limitations of these strategies, while identifying underexplored gaps in current knowledge and practice. Furthermore, the review delineates future research trajectories to bridge these gaps and advance personalized care, ultimately aiming to improve clinical outcomes and patient-centered management.

Indexed as

hyperandrogenisminsulin resistancelifestyle interventionspharmacological treatmentpolycystic ovary syndrome

Identifiers

PMID41884102
PMCPMC13012536

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.